Skip to Content

93 7351 93 7351 (Lansoprazole Delayed Release 30 mg)

Pill with imprint 93 7351 93 7351 is Gray & Pink, Capsule-shape and has been identified as Lansoprazole Delayed Release 30 mg. It is supplied by Teva Pharmaceuticals USA.

Lansoprazole is used in the treatment of gerd; barrett's esophagus; duodenal ulcer; aspiration pneumonia; duodenal ulcer prophylaxis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7351 93 7351

Lansoprazole delayed release 30 mg 93 7351 93 7351
Lansoprazole delayed release 30 mg 93 7351 93 7351
Lansoprazole delayed release 30 mg 93 7351 93 7351

Lansoprazole Delayed Release

Imprint:
93 7351 93 7351
Strength:
30 mg
Color:
Gray & Pink
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
ferrosoferric oxide
gelatin
hypromellose 2910 (6 mPa.s)
magnesium carbonate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
propylene glycol
ferric oxide red
shellac
sucrose
corn starch
magnesium silicate
titanium dioxide
triethyl citrate
potassium hydroxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
42291-0365 AvKare, Inc.
54868-6086 Physicians Total Care Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide